4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy
Clinical trial NCT03278665 · COMPLETED
Trial details
- NCT number
- NCT03278665
- Sponsor
- 4SC AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2022-02-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.